Drug Trial Radar · NCT01245569
A Study in Patients With Chronic Obstructive Pulmonary Disease
Last checked: Nov 20, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
419
Actual
Start
Apr 12, 2011
Primary completion
Mar 13, 2012
Study completion Mar 13, 2012
Sponsor
- Lead sponsor
- Chiesi Farmaceutici S.p.A.Industry
- Sponsor type
- Industry
- First posted
- Nov 22, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of the study was to demonstrate the superiority of Foster® 100/6 (two puffs b.i.d.) versus Seretide® 500/50 (one inhalation b.i.d.), in terms of pulmonary function (AUC0-30min standardized by time of change from pre-dose in FEV1) after drug inhalation in the morning of day 1, and the equivalence between Foster® 100/6 (two puffs b.i.d.) and Seretide® 500/50 (one inhalation b.i.d.) in terms of Transition Dyspnoea Index (TDI) score at day 84 in patients with COPD. The secondary objectives of the study were: * To evaluate the efficacy of the test treatments in terms of additional spirometric parameters and of clinical outcome measures; * To assess the safety and tolerability; * To perform an exploratory analysis evaluating the consumption of resources deriving from COPD management in the perspective of the Healthcare System.
Conditions
- Chronic Obstructive Pulmonary Disease
Interventions
Beclomethasone Dipropionate - FormoterolDrug
Administered via a pressurized metered-dose inhaler
Fluticasone - SalmeterolDrug
Administered via a pressurized metered-dose inhaler
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the Curve (AUC) 0-30min Standardized by Time of Change From Pre-dose in Forced Expiratory Volume in One Second (FEV1) in the Morning of Day 1Time frame: on Day 1 (V2)
- Transition Dyspnoea Index (TDI) Score at Day 84Time frame: Day 84 (V5)
Locations
68 sites in 10 countries. Site status is shown where the registry gives one.
Aarhus University Hospital
Aarhus, Denmark
Bispebjerg Hospital
Copenhagen, Denmark
Dept. of Cardiology and Respiratory Medicine
Copenhagen, Denmark
Gentofte Hospital
Gentofte Municipality, Denmark
Odense University Hospital
Odense, Denmark
Centre Hospitalier
Toulon, France
Praxis Dr. Jorg Kampschulte
Berlin, Germany
Praxis Dr. Jörg Winkler
Leipzig, Germany
KLB Healthresearch
Lübeck, Germany
KLD Helthreseach
Lübeck, Germany
SMO.MD GmbH Zentrum für Klinische Studien
Magdeburg, Germany
Pneumologische Gemeinschaftspraxis Saarbrücken
Saarbrücken, Germany
Fachinternistische Gemeinschafts
Wedel, Germany
Pneumologische Praxis Dr Redlich
Wiesloch, Germany
Gemeinschaftspraxis für Pneumologie
Wuppertal, Germany
Dr. Kenessey Albert Kórház - Rendelőintézet
Balassagyarmat, Hungary
Békés Megyei Képviselő-testület Pándy Kálmán Kórház
Békés, Hungary
Szabolcs-Szatmár-Bereg Megyei Önkormányzat Jósa András Oktató Kórház
Budapest, Hungary
Centrum-Tüdőgyógyászati Klinika
Debrecen, Hungary
Bács-Kiskun Megeyi Önkormanyzat...
Kecskemét, Hungary
Karolina Kórház és Rendelőintézet Tüdőgyógyászat
Mosonmagyaróvár, Hungary
Békés Megyei Képviselő-testület Pándy Kálmán Kórház
Nyíregyháza, Hungary
Jósa András Hospital
Nyíregyháza, Hungary
Chiesi Clinical Centre Szigetszentmiklös
Szigetszentmiklös, Hungary
Ospedale Sant'Orsola-Malpighi
Bologna, Italy
A.O. Policlinico
Catania, Italy
A.O. S. Gerardo
Monza, Italy
Azienda Ospedaliera Monaldi
Naples, Italy
Università di Pisa
Pisa, Italy
IRCCS San Raffaele La Pisana
Roma, Italy
Policlinico Umberto I - VIII Padiglione
Rome, Italy
NZOZ "Non Nocere"
Gdansk, Poland
Niepubliczny Zakład Opieki Zdrowotnej "PROFILAKTYKA"
Koszalin, Poland
Szpital Specjalistyczny im Jana Pawła II
Krakow, Poland
Szpital Uniwersytecki w Krakowie
Krakow, Poland
Prywatny Gabinet Specjalistyczny
Lodz, Poland
Samodzielny Publiczny Szpital Kliniczny
Szczecin, Poland
Chorób Płuc
Warsaw, Poland
Gabinet Lekarski SERIA IWONA GRZELEWSKA-RZYMOWSKA
Warsaw, Poland
Instytut Gruźlicy i Chorób Płuc. Zakład Diagnostyki i Leczenia Niewydolności Oddychania
Warsaw, Poland
Showing 40 of 68 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.